| 28/09/22 | 16:35:47 | 28 Sept 2022 | | Price Monitoring Extension |
| 28/09/22 | 07:00:11 | 28 Sept 2022 | | Contravention of the TGA Advertising Code |
| 23/09/22 | 07:00:08 | 23 Sept 2022 | | US$550,000 funding received under Mercer Facility |
| 21/09/22 | 07:00:07 | 21 Sept 2022 | | CimetrA™ Dose Finding Study Interim Results |
| 08/09/22 | 12:47:34 | 8 Sept 2022 | | Website / Social Media update |
| 06/09/22 | 11:30:19 | 6 Sept 2022 | | Dispatch of General Meeting Documents |
| 01/09/22 | 07:00:08 | 1 Sept 2022 | | Preliminary Financial Report for 30 June 2022 |
| 25/08/22 | 07:00:04 | 25 Aug 2022 | | Final Payment for Malta GMP Manufacturing Plant |
| 17/08/22 | 07:00:07 | 17 Aug 2022 | | AMC Holdings, Inc. places US$1M ArtemiC™ order |
| 15/08/22 | 07:00:07 | 15 Aug 2022 | | CannEpil® Clinical Study on Driving Performance |
| 11/08/22 | 11:05:43 | 11 Aug 2022 | | Second Price Monitoring Extn |
| 11/08/22 | 11:00:19 | 11 Aug 2022 | | Price Monitoring Extension |
| 08/08/22 | 10:30:06 | 8 Aug 2022 | | Updated Investor Presentation |
| 03/08/22 | 07:00:07 | 3 Aug 2022 | | First Tranche of Mercer Street Funding Received |
| 29/07/22 | 07:00:14 | 29 Jul 2022 | | US$10m Financing Agreement with Mercer Street |
| 28/07/22 | 07:45:01 | 28 Jul 2022 | | Purchase of Strategic 40% Stake in AI Software |
| 25/07/22 | 07:00:07 | 25 Jul 2022 | | June Quarterly Activities Report and Cash Flow |
| 19/07/22 | 07:00:08 | 19 Jul 2022 | | Chief Commercial Officer Appointment |
| 14/07/22 | 16:41:24 | 14 Jul 2022 | | Second Price Monitoring Extn |
| 14/07/22 | 16:36:15 | 14 Jul 2022 | | Price Monitoring Extension |
| 14/07/22 | 14:05:56 | 14 Jul 2022 | | Second Price Monitoring Extn |
| 14/07/22 | 14:00:45 | 14 Jul 2022 | | Price Monitoring Extension |
| 14/07/22 | 11:05:36 | 14 Jul 2022 | | Second Price Monitoring Extn |
| 14/07/22 | 11:00:29 | 14 Jul 2022 | | Price Monitoring Extension |
| 14/07/22 | 09:05:25 | 14 Jul 2022 | | Second Price Monitoring Extn |
| 14/07/22 | 09:00:20 | 14 Jul 2022 | | Price Monitoring Extension |
| 14/07/22 | 07:16:44 | 14 Jul 2022 | | Clinical Study results - patients with Long COVID |
| 08/07/22 | 07:00:05 | 8 Jul 2022 | | Approval Granted for CimetrA Dose Finding Study |
| 06/07/22 | 08:00:01 | 6 Jul 2022 | | Launch of ZAM - Medical data App |
| 27/06/22 | 07:00:08 | 27 Jun 2022 | | CimetrATM Pre-clinical Trial Progress Report |
| 24/06/22 | 07:00:04 | 24 Jun 2022 | | USA Market Update: CimetrA Clinical Trial Progress |
| 16/06/22 | 07:00:08 | 16 Jun 2022 | | Successful Glioblastoma Pre-clinical Trial Results |
| 06/06/22 | 07:00:54 | 6 Jun 2022 | | CogniCann© Phase II Clinical Trial Results |
| 27/05/22 | 13:08:18 | 27 May 2022 | | Compliance Filing of UK subsidiary FY21 Accounts |
| 23/05/22 | 10:43:24 | 23 May 2022 | | Application for Admission to Trading |
| 20/05/22 | 07:00:08 | 20 May 2022 | | Academic Paper on Effect of ArtemiC™ Published |
| 18/05/22 | 12:06:58 | 18 May 2022 | | Director/PDMR Shareholding |
| 10/05/22 | 07:01:01 | 10 May 2022 | | CannEpil® Drug Delivery System Patent Approval |
| 09/05/22 | 12:28:24 | 9 May 2022 | | Director/PDMR Shareholding |
| 06/05/22 | 15:08:44 | 6 May 2022 | | Replacement: Director/PDMR Shareholding |
| 05/05/22 | 11:10:01 | 5 May 2022 | | Director/PDMR Shareholding |
| 04/05/22 | 07:00:05 | 4 May 2022 | | Partnership with HempStreet |
| 29/04/22 | 16:41:36 | 29 Apr 2022 | | Second Price Monitoring Extn |
| 29/04/22 | 16:35:57 | 29 Apr 2022 | | Price Monitoring Extension |
| 29/04/22 | 10:03:00 | 29 Apr 2022 | | March Quarterly Activities Report and Cash Flow |
| 26/04/22 | 07:00:15 | 26 Apr 2022 | | Appointment of new Chief Financial Officer |
| 25/04/22 | 11:08:18 | 25 Apr 2022 | | Application for Admission to Trading |
| 21/04/22 | 07:00:07 | 21 Apr 2022 | | CimetrA™ Patent Approved by European IP Office |
| 12/04/22 | 08:36:42 | 12 Apr 2022 | | Performance Rights and Change of CFO |
| 07/04/22 | 10:35:37 | 7 Apr 2022 | | Director/PDMR Shareholding |
